Transmucosal and subcutaneous compositions

作者: Li Peng , Yao Wei , Davis Robert

DOI:

关键词:

摘要: The disclosure provides new transmucosal and subcutaneous pharmaceutical compositions comprising 1-(4-fluoro-phenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one or 1-(4-fluoro-phenyl)-4-((6bR,10aS)-2,2-d2-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one -(4-fluoro-phenyl)-4-((6bR,10aS)-1,1,2,2-d4-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one, in free base, co-crystal salt form, together with methods of making using them.

参考文章(165)
John P. Wolfe, Stephen L. Buchwald, Michael Palucki, Palladium-catalysed synthesis of aryl ethers ,(1997)
Anthony W. Czarnik, Deuterium-enriched asenapine ,(2008)
Anthony W. Czarnik, Deuterium-enriched eplivanserin ,(2008)
John Charles Tomesch, Andrew S. Thompson, James David Beard, Hua Cheng, Wei Yao, Peng Li, Qiang Zhang, Substituted heterocycle fused gamma-carbolines synthesis ,(2008)
John P. Wolfe, Stephen L. Buchwald, Michael Palucki, Synthesis of aryl ethers ,(1996)
Stephen Byrn, Ralph Pfeiffer, Michael Ganey, Charles Hoiberg, Guirag Poochikian, Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations Pharmaceutical Research. ,vol. 12, pp. 945- 954 ,(1995) , 10.1023/A:1016241927429
John Tomesch, Lawrence P. Wennogle, Substituted heterocycle fused gamma-carbolines solid ,(2009)
Gayatri Sathyan, Sonya Seroff, Suneel K. Gupta, Iran Reyes, Julie Lee, Atul D. Ayer, Nipun Davar, Nyomi V. Yam, Methods and dosage forms for controlled delivery of paliperidone and risperidone ,(2009)